High STK31 levels in the primary tumor may be prognostic for high risk of metastasis and correlate with an increased patient mortality, rendering it a potential prognostic factor, biological marker of tumor invasiveness and therapeutic target. The gene discussed is STK31; the disease is neoplasm.